Product Name

  • Name

    Sevoflurane

  • EINECS -0
  • CAS No. 28523-86-6
  • Article Data29
  • CAS DataBase
  • Density 1.505 g/cm3
  • Solubility insoluble in water
  • Melting Point 58 °C
  • Formula C4H3F7O
  • Boiling Point 49.5 °C at 760 mmHg
  • Molecular Weight 200.056
  • Flash Point 58 °C
  • Transport Information
  • Appearance colorless liquid
  • Safety 26-36/37/39
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 28523-86-6 (Sevoflurane)
  • Hazard Symbols IrritantXi
  • Synonyms Ether,fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl (8CI);347mmzEbg;Fluoromethyl1,1,1,3,3,3-hexafluoroisopropyl ether;Fluoromethyl2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether;MR 6S4;R-E 347;Sevocris;Sevoflo;Sevofluran;Sevorane;Ultane;
  • PSA 9.23000
  • LogP 2.42320

Synthetic route

1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether
26103-07-1

1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With diisopropylethylamine hydrofluoride for 16h; Heating;95%
With potassium fluoride; potassium hydrogenfluoride; water; Aliquat HTA-1 at 100℃; for 3h; Product distribution / selectivity;90%
With potassium fluoride; tetraethylammonium chloride In water at 100℃; for 3h; Product distribution / selectivity;86%
1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether
26103-07-1

1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether

A

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

B

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With hydrogenchloride; potassium fluoride; water; Aliquat HTA-1 at 100℃; for 3h; Product distribution / selectivity;A 1.05 %Chromat.
B 93%
With potassium fluoride; potassium hydrogenfluoride; water; Aliquat 175 at 100℃; for 3h; Product distribution / selectivity;A 3.8 %Chromat.
B 89%
With potassium fluoride; potassium hydrogenfluoride; water; benzyl triethyl ammonium dichloride at 100℃; for 3h; Product distribution / selectivity;A 4 %Chromat.
B 88%
fluoroiodomethane
373-53-5

fluoroiodomethane

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With triethylamine In acetonitrile at 60℃; for 8h; Product distribution / selectivity; Inert atmosphere; Sealed vesselaturated gas;91.43%
With triethylamine; potassium hydroxide In acetonitrile at 60℃; for 8h; Product distribution / selectivity; Inert atmosphere;91.43%
1,3,5-Trioxan
110-88-3

1,3,5-Trioxan

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
boron trifluoride diethyl etherate for 5h; Product distribution / selectivity; Heating / reflux;84%
aluminum(III) fluoride In chloroform for 5h; Product distribution / selectivity; Heating / reflux;72%
With hydrogen fluoride at -30 - 67℃; under 2257.73 - 3862.89 Torr; Pressure; Temperature;
S-monofluoromethyl-S-phenyl-2,3,4,5-tetramethylphenylsulphonium tetrafluoroborate

S-monofluoromethyl-S-phenyl-2,3,4,5-tetramethylphenylsulphonium tetrafluoroborate

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 20℃;83%
bromofluoromethane
373-52-4

bromofluoromethane

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With triethylamine In acetonitrile at 60℃; for 8h; Product distribution / selectivity; Inert atmosphere; Sealed vessel;81.8%
With triethylamine; potassium hydroxide In acetonitrile at 60℃; for 8h; Product distribution / selectivity; Inert atmosphere;81.8%
1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With sodium carbonate In 1-methyl-pyrrolidin-2-one; water at 50℃; for 6h; Product distribution / selectivity; Sealed vessel;71.57%
With 1-methyl-pyrrolidin-2-one; sodium carbonate In water at 50℃; for 6h;71.57%
1,3,5-tri-O-benzoyl-2-deoxy-2-fluoro-α-D-arabinofuranose
97614-43-2

1,3,5-tri-O-benzoyl-2-deoxy-2-fluoro-α-D-arabinofuranose

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With potassium fluoride In various solvent(s) at 95℃; for 1h; Substitution;71%
bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether
194039-83-3

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With hydrogen fluoride at -30 - 70℃; for 1.5h;53%
methyl 3,3,3-trifluoro-2-trifluoromethyl-2-chloromethoxypropionate
1152045-94-7

methyl 3,3,3-trifluoro-2-trifluoromethyl-2-chloromethoxypropionate

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With potassium fluoride In polyethyleneglycol at 90 - 95℃; for 5h; Product distribution / selectivity; Autoclave;51.7%
1,3,5-Trioxan
110-88-3

1,3,5-Trioxan

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

A

formaldehyde methyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal
194039-87-7

formaldehyde methyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

B

formaldehyde fluoromethyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal
194039-91-3

formaldehyde fluoromethyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

C

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether
194039-83-3

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether

D

sevoflurane
28523-86-6

sevoflurane

E

formaldehyde di[2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

formaldehyde di[2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

Conditions
ConditionsYield
With hydrogen fluoride at 31 - 65℃; under 1275.13 - 2467.75 Torr; for 6h; Inert atmosphere;A n/a
B n/a
C n/a
D 23%
E n/a
1,3,5-Trioxan
110-88-3

1,3,5-Trioxan

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

A

formaldehyde fluoromethyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal
194039-91-3

formaldehyde fluoromethyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

B

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether
194039-83-3

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether

C

sevoflurane
28523-86-6

sevoflurane

D

formaldehyde di[2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

formaldehyde di[2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

Conditions
ConditionsYield
With hydrogen fluoride at 56 - 65℃; under 1275.13 - 2467.75 Torr; for 6h; Inert atmosphere;A n/a
B n/a
C 23%
D n/a
bis(2-chloromethyl)ether
542-88-1

bis(2-chloromethyl)ether

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With BrF3
Na2 SO3

Na2 SO3

(CF3)2 CHOCH2 F

(CF3)2 CHOCH2 F

(ClF2 C)(F3 C)CHOCH2 F

(ClF2 C)(F3 C)CHOCH2 F

(ClF2 C)2 CHOCH2 F

(ClF2 C)2 CHOCH2 F

1,1,1,3,3,3-hexachloro-2-methoxy-propane
98020-32-7

1,1,1,3,3,3-hexachloro-2-methoxy-propane

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With sodium hydroxide In BrF3
methyl 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propionate
7594-51-6

methyl 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propionate

C6H5F7O3
1000699-24-0

C6H5F7O3

Methyl 3,3,3-trifluoro-2-trifluoromethyl-2-methoxypropionate
13859-30-8

Methyl 3,3,3-trifluoro-2-trifluoromethyl-2-methoxypropionate

A

potassium 3,3,3-trifluoro-2-trifluoromethyl-2-hydroxypropionate
118217-64-4

potassium 3,3,3-trifluoro-2-trifluoromethyl-2-hydroxypropionate

B

MTTMP; potassium salt
960005-34-9

MTTMP; potassium salt

C

sevoflurane
28523-86-6

sevoflurane

D

1,1,1,3,3,3-hexafluoro-2-methoxypropane
13171-18-1

1,1,1,3,3,3-hexafluoro-2-methoxypropane

Conditions
ConditionsYield
With potassium hydroxide; water at 50℃; for 2h;A 99 %Spectr.
B 71 %Spectr.
C 89 %Spectr.
D 5 %Spectr.
With water; potassium carbonate at 50℃;
diethyl-2-(chloromethoxy)malonate
1265520-63-5

diethyl-2-(chloromethoxy)malonate

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With sulfur tetrafluoride; hydrogen fluoride In Solkane365 mfc at 23 - 100℃; under 45004.5 Torr; Product distribution / selectivity;
1,1,1,3,3,3-hexafluoro-2-bromomethoxy-propane
28523-90-2

1,1,1,3,3,3-hexafluoro-2-bromomethoxy-propane

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With potassium fluoride In sulfolane; 2,2'-[1,2-ethanediylbis(oxy)]bisethanol at 85℃; for 6h;
With potassium fluoride In sulfolane; 2,2'-[1,2-ethanediylbis(oxy)]bisethanol at 85℃; for 6h; Product distribution / selectivity;
iodomethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
1093627-71-4

iodomethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With potassium fluoride In N,N-dimethyl-formamide; 2,2'-[1,2-ethanediylbis(oxy)]bisethanol at 85℃; for 6h;
With potassium fluoride In N,N-dimethyl-formamide; 2,2'-[1,2-ethanediylbis(oxy)]bisethanol at 85℃; for 6h; Product distribution / selectivity;
1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

bis(fluoromethyl)-ether
462-51-1

bis(fluoromethyl)-ether

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
trifluorormethanesulfonic acid In dichloromethane at 25℃; for 15h; Product distribution / selectivity; Polyethylene container;58 %Chromat.
at 20℃; for 1h;
1,1,1,3,3-pentafluorobutane
406-58-6

1,1,1,3,3-pentafluorobutane

diethyl-2-(chloromethoxy)malonate
1265520-63-5

diethyl-2-(chloromethoxy)malonate

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With sulfur tetrafluoride; hydrogen fluoride at 23 - 100℃; under 45004.5 Torr; Autoclave;
C4H5FO5
1393107-41-9

C4H5FO5

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
With sulfur tetrafluoride
formaldehyd
50-00-0

formaldehyd

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

Conditions
ConditionsYield
Stage #1: formaldehyd; 1,1,1,3',3',3'-hexafluoro-propanol With hydrogen fluoride In dichloromethane Cooling with ice;
Stage #2: With sulfuric acid at 20℃; for 1h;
sevoflurane
28523-86-6

sevoflurane

1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether
26103-07-1

1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether

Conditions
ConditionsYield
In water79%
sevoflurane
28523-86-6

sevoflurane

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether
58109-34-5

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether

Conditions
ConditionsYield
With methyllithium In formaldehyde diethyl acetal at -31 - -20℃; Product distribution / selectivity; Inert atmosphere;50%
With lithium hexamethyldisilazane In tetrahydrofuran at -70℃; for 0.25h; Yield given;
sevoflurane
28523-86-6

sevoflurane

sodium methylate
124-41-4

sodium methylate

Fluoromethyl 2-methoxy-2,2-difluoro-1-(trifluoromethyl)ethyl ether
58109-33-4

Fluoromethyl 2-methoxy-2,2-difluoro-1-(trifluoromethyl)ethyl ether

Conditions
ConditionsYield
In methanol 1.) 15-22 deg C, 45 min; 2.) RT 1 3/4 h; 3.) reflux, 2 h;4.9 g
sevoflurane
28523-86-6

sevoflurane

sodium methylate
124-41-4

sodium methylate

A

Fluoromethyl 2-methoxy-2,2-difluoro-1-(trifluoromethyl)ethyl ether
58109-33-4

Fluoromethyl 2-methoxy-2,2-difluoro-1-(trifluoromethyl)ethyl ether

B

fluoromethyl 1-methoxy-1,3,3,3-tetrafluoro-2-propenyl ether

fluoromethyl 1-methoxy-1,3,3,3-tetrafluoro-2-propenyl ether

Conditions
ConditionsYield
at 35 - 40℃; for 0.5h; Yields of byproduct given;A n/a
B 0.375 g
sevoflurane
28523-86-6

sevoflurane

fluoromethyl 1-cyano-2,2,2-trifluoroethyl ether

fluoromethyl 1-cyano-2,2,2-trifluoroethyl ether

Conditions
ConditionsYield
With potassium carbonate; lithium hexamethyldisilazane In tetrahydrofuran at -65 - 0℃; for 0.5h; Yield given;
sevoflurane
28523-86-6

sevoflurane

A

Fluoromethyl 2-methoxy-2,2-difluoro-1-(trifluoromethyl)ethyl ether
58109-33-4

Fluoromethyl 2-methoxy-2,2-difluoro-1-(trifluoromethyl)ethyl ether

B

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether
58109-34-5

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether

C

(Z)-1,3,3,3-Tetrafluoro-2-fluoromethoxy-1-methoxy-propene

(Z)-1,3,3,3-Tetrafluoro-2-fluoromethoxy-1-methoxy-propene

D

1,1,3,3-Tetrafluoro-2-fluoromethoxy-3-methoxy-propene

1,1,3,3-Tetrafluoro-2-fluoromethoxy-3-methoxy-propene

Conditions
ConditionsYield
With soda lime at 120℃; for 0.666667h; Product distribution; Mechanism; further time and temperature; also with D2-sevoflurane;
sevoflurane
28523-86-6

sevoflurane

diisopropylethylamine hydrofluoride

diisopropylethylamine hydrofluoride

Conditions
ConditionsYield
With hydrogenchloride; hydrogen fluoride; N-ethyl-N,N-diisopropylamine In 1,1,1,3,3,3-hexafluoroisopropyl chloromethyl ether; water
1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

sevoflurane
28523-86-6

sevoflurane

formaldehyde di[2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

formaldehyde di[2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

sevoflurane
28523-86-6

sevoflurane

C4H4F6O2

C4H4F6O2

Conditions
ConditionsYield
With aluminum oxide; Trimethylsilanol
C5H6F6O3

C5H6F6O3

sevoflurane
28523-86-6

sevoflurane

A

C6H7F7O3
194039-95-7

C6H7F7O3

B

dihexafluoro isopropanol triformal
1016982-73-2

dihexafluoro isopropanol triformal

C4H4F6O2

C4H4F6O2

sevoflurane
28523-86-6

sevoflurane

A

formaldehyde fluoromethyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal
194039-91-3

formaldehyde fluoromethyl [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] acetal

B

1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

C4H4F6O2

C4H4F6O2

sevoflurane
28523-86-6

sevoflurane

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether
194039-83-3

bis {[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]methyl} ether

Sevoflurane History

First reports of sevoflurane appeared in the literature in 1971. The agent was developed by scientists at Baxter Laboratories. It was introduced into clinical practice initially in Japan in 1990. The rights for sevoflurane in the US and other countries are held by Abbott Laboratories.

Sevoflurane Consensus Reports

Sevoflurane is reported in EPA TSCA Inventory. Glycol ether compounds are on the Community Right-To-Know List.The U.S. Environmental Protection Agency(EPA) has classified sevoflurane as a greenhouse gas, with a global warming potential of 345. One tonne of sevoflurane emitted is equivalent to 345 tonnes of carbon dioxide in the atmosphere.

Sevoflurane Specification

The Sevoflurane with CAS registry number of 28523-86-6 is also known as Ether,fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl (8CI). The IUPAC name is 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane. It belongs to product categories of Fluoro Series. In addition, the formula is C4H3F7O and the molecular weight is 200.05. This chemical is a colorless liquid and should be stored in refrigerated place away from oxidizing agents. It is used as inhalation anesthetic.

Physical properties about Sevoflurane are: (1)ACD/LogP: 2.48; (2)ACD/LogD (pH 5.5): 2.48; (3)ACD/LogD (pH 7.4): 2.48; (4)ACD/BCF (pH 5.5): 45.27; (5)ACD/BCF (pH 7.4): 45.27; (6)ACD/KOC (pH 5.5): 533.13; (7)ACD/KOC (pH 7.4): 533.13; (8)#H bond acceptors: 1; (9)#Freely Rotating Bonds: 2; (10)Index of Refraction: 1.266; (11)Molar Refractivity: 23.36 cm3; (12)Molar Volume: 139.5 cm3; (13)Surface Tension: 13 dyne/cm; (14)Density: 1.433 g/cm3; (15)Enthalpy of Vaporization: 28.08 kJ/mol; (16)Boiling Point: 49.5 °C at 760 mmHg; (17)Vapour Pressure: 311 mmHg at 25 °C.

Preparation of Sevoflurane: it is prepared by reaction of hexafluoroacetone with catalyst Pd-carbon. After hexafluoro isopropanol is obtained, add formaldehyde, hydrogen fluoride and sulfuric acid to the reaction product to generate product.

Sevoflurane is prepared by reaction of hexafluoroacetone with catalyst Pd-carbon.

When you are using this chemical, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. During using it, wear suitable protective clothing, gloves and eye/face protection. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
1. Canonical SMILES: C(OC(C(F)(F)F)C(F)(F)F)F
2. InChI: InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2
3. InChIKey: DFEYYRMXOJXZRJ-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LC50 inhalation 28300ppm/3H (28300ppm) BEHAVIORAL: TREMOR

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Kiso to Rinsho. Clinical Report. Vol. 21, Pg. 5497, 1987.
mouse LD50 intraperitoneal 10500mg/kg (10500mg/kg)   Drugs in Japan Vol. -, Pg. 591, 1990.
mouse LD50 oral 18200mg/kg (18200mg/kg)   Drugs in Japan Vol. -, Pg. 591, 1990.
rat LC50 inhalation 28800ppm/3H (28800ppm) BEHAVIORAL: TREMOR

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Kiso to Rinsho. Clinical Report. Vol. 21, Pg. 5497, 1987.
rat LD50 intraperitoneal 6300mg/kg (6300mg/kg)   Drugs in Japan Vol. -, Pg. 591, 1990.
rat LD50 oral 10800mg/kg (10800mg/kg)   Drugs in Japan Vol. -, Pg. 591, 1990.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View